Drug or treatment
Budigalimab clinical trials
As of November 12, 2026, Find a Trial lists 2 clinical trials of Budigalimab that are recruiting, at sites in 6 countries (most in Canada (2), Israel (2), Japan (2)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
Trying oral ABBV-711 alone and with budigalimab for advanced squamous tumors.
This trial will test whether oral ABBV-711, alone or with the antibody budigalimab, is safe and can help adults whose advanced squamous tumors have progressed after standard treatments.
-
Assessing the safety and effects of Azirkitug in cancer patients
This study is testing a new cancer drug called Azirkitug to see how safe it is and how well it works for adults with certain types of lung and head and neck cancers.
Quick answers
How many clinical trials of Budigalimab are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Canada (2 trials), Israel (2 trials), Japan (2 trials), United States (2 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.